Group 1 - The A-share market continues to show strength in innovative drug concept stocks, with notable gains in several companies, including Baiter-U nearing the daily limit and reaching a new high since its listing [1] - Specific stock performances include: Baiter-U up 19.95% with a market cap of 22.3 billion, Yuandong Bio up 9.33% with a market cap of 11.5 billion, and Hongbo Pharma up 8.16% with a market cap of 4.867 billion [2] - The National Medical Products Administration (NMPA) is set to support the "China first launch" of innovative drugs, with plans to enhance services across the entire chain from communication to clinical trials and registration for new mechanisms and targets [2][3] Group 2 - The NMPA announced measures to expedite the approval process for urgently needed overseas drugs that are already on the market, aiming to meet the pressing clinical needs of patients [3]
国家药监局重磅发声，创新药概念股集体走强，必贝特创上市新高